Statera Biopharma, Inc. Increase (Decrease) in Prepaid Expense
Statera Biopharma, Inc. reported Increase (Decrease) in Prepaid Expense of -$884.38 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2022-11-14
- Statera Biopharma, Inc. increase (decrease) in prepaid expense for the quarter ending 2022-09-30 was -$149.49K, a 105.56% decline year-over-year.
- Statera Biopharma, Inc. increase (decrease) in prepaid expense for the quarter ending 2022-06-30 was -$252.79K.
- Statera Biopharma, Inc. increase (decrease) in prepaid expense for the quarter ending 2022-03-31 was -$482.10K.
- Statera Biopharma, Inc. increase (decrease) in prepaid expense for the quarter ending 2021-12-31 was -$1.71M.
- Statera Biopharma, Inc. increase (decrease) in prepaid expense for fiscal 2021 was $981.89K.
- Statera Biopharma, Inc. increase (decrease) in prepaid expense for fiscal 2020 was $0.00.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$149.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$402.28K derived: sum of 2 quarters · filed 2022-11-14 | -$884.38K 10-Q · filed 2022-11-14 | -$2.59M derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | -$252.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-28 | -$734.89K 10-Q · filed 2022-10-28 | -$2.44M derived: sum of 3 quarters · filed 2022-10-28 | $247.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-03-31 | -$482.10K 10-Q · filed 2022-10-21 | -$2.19M derived: sum of 2 quarters · filed 2022-10-21 | $499.79K derived: sum of 3 quarters · filed 2022-11-14 | $499.79K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-12-31 | -$1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-06 | $981.89K derived: sum of 2 quarters · filed 2022-11-14 | $981.89K derived: sum of 3 quarters · filed 2022-11-14 | $981.89K 10-K · filed 2022-10-06 |
| 2021-09-30 | $2.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $2.69M derived: sum of 2 quarters · filed 2022-11-14 | $2.69M 10-Q · filed 2022-11-14 | $2.69M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-28 | $0.00 10-Q · filed 2022-10-28 | $0.00 derived: sum of 3 quarters · filed 2022-10-28 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-10-21 | $0.00 derived: sum of 2 quarters · filed 2022-10-21 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-06 | $0.00 10-K · filed 2022-10-06 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 |